☰

Spencer Bujarski - Publications

Affiliations: 
University of California, Los Angeles, Los Angeles, CA 
Area:
addiction
Tree Info Grants Similar researchers PubMed Report error

53 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Grodin EN, Donato S, Du H, Green R, Bujarski S, Ray LA. Response to Letter to the Editors regarding 'A Meta-Regression of Trial Features Predicting the Effects of Alcohol Use Disorder Pharmacotherapies on Drinking Outcomes in Randomized Clinical Trials: A Secondary Data Analysis'. Alcohol and Alcoholism (Oxford, Oxfordshire). PMID 37794750 DOI: 10.1093/alcalc/agad066  0.407
2022 Grodin EN, Donato S, Du H, Green R, Bujarski S, Ray LA. A Meta-Regression of Trial Features Predicting the Effects of Alcohol Use Disorder Pharmacotherapies on Drinking Outcomes in Randomized Clinical Trials: A Secondary Data Analysis. Alcohol and Alcoholism (Oxford, Oxfordshire). PMID 35229869 DOI: 10.1093/alcalc/agac004  0.399
2021 Nieto SJ, Baskerville W, Donato S, Bujarski S, Ray L. Lifetime heavy drinking years predict alcohol use disorder severity over and above current alcohol use. The American Journal of Drug and Alcohol Abuse. 1-8. PMID 34134588 DOI: 10.1080/00952990.2021.1938100  0.599
2021 Green R, Du H, Grodin EN, Nieto SJ, Bujarski S, Roche DJO, Ray LA. A meta-regression of methodological features predicting the effects of pharmacotherapies on subjective response to alcohol. Alcoholism, Clinical and Experimental Research. PMID 34120356 DOI: 10.1111/acer.14643  0.599
2021 Grodin EN, Bujarski S, Towns B, Burnette E, Nieto S, Lim A, Lin J, Miotto K, Gillis A, Irwin MR, Evans C, Ray LA. Ibudilast, a neuroimmune modulator, reduces heavy drinking and alcohol cue-elicited neural activation: a randomized trial. Translational Psychiatry. 11: 355. PMID 34120149 DOI: 10.1038/s41398-021-01478-5  0.554
2020 Ray LA, Du H, Green R, Roche DJO, Bujarski S. Do behavioral pharmacology findings predict clinical trial outcomes? A proof-of-concept in medication development for alcohol use disorder. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 33235284 DOI: 10.1038/s41386-020-00913-3  0.486
2020 Grodin EN, Montoya AK, Bujarski S, Ray LA. Modeling motivation for alcohol in humans using traditional and machine learning approaches. Addiction Biology. e12949. PMID 32725863 DOI: 10.1111/Adb.12949  0.646
2020 Grodin EN, Nguyen XT, Ho D, Bujarski S, Ray LA. Sensitivity and specificity of a commercial urinary ethyl glucuronide (ETG) test in heavy drinkers. Addictive Behaviors Reports. 11: 100249. PMID 32467838 DOI: 10.1016/J.Abrep.2020.100249  0.535
2019 Ray LA, Du H, Grodin E, Bujarski S, Meredith L, Ho D, Nieto S, Wassum K. Capturing habitualness of drinking and smoking behavior in humans. Drug and Alcohol Dependence. 207: 107738. PMID 31816490 DOI: 10.1016/J.Drugalcdep.2019.107738  0.377
2019 Grodin EN, Bujarski S, Venegas A, Baskerville WA, Nieto SJ, Jentsch JD, Ray LA. Reward, Relief and Habit Drinking: Initial Validation of a Brief Assessment Tool. Alcohol and Alcoholism (Oxford, Oxfordshire). PMID 31557278 DOI: 10.1093/Alcalc/Agz075  0.597
2019 Hartwell EE, Bujarski S, Green R, Ray LA. Convergence between the Penn Alcohol Craving Scale and diagnostic interview for the assessment of alcohol craving. Addictive Behaviors Reports. 10: 100198. PMID 31304230 DOI: 10.1016/J.Abrep.2019.100198  0.615
2019 Lim AC, Ghahremani DG, Grodin EN, Green R, Bujarski S, Hartwell EE, Courtney KE, Hutchison K, Miotto K, Ray LA. Neuroimaging findings from an experimental pharmacology trial of naltrexone in heavy drinkers of East Asian descent. Drug and Alcohol Dependence. PMID 31160146 DOI: 10.1016/J.Drugalcdep.2019.02.028  0.531
2019 Ray LA, Green R, Roche DJO, Magill M, Bujarski S. Naltrexone effects on subjective responses to alcohol in the human laboratory: A systematic review and meta-analysis. Addiction Biology. PMID 31148304 DOI: 10.1111/Adb.12747  0.61
2019 Roche DJO, Bujarski S, Green R, Hartwell EE, Leventhal AM, Ray LA. Alcohol, tobacco, and marijuana consumption is associated with increased odds of same-day substance co- and tri-use. Drug and Alcohol Dependence. 200: 40-49. PMID 31085377 DOI: 10.1016/J.Drugalcdep.2019.02.035  0.621
2019 Green R, Grodin E, Lim AC, Venegas A, Bujarski S, Krull J, Ray LA. The interplay between subjective response to alcohol, craving, and alcohol self-administration in the human laboratory. Alcoholism, Clinical and Experimental Research. PMID 30860603 DOI: 10.1111/Acer.14001  0.624
2019 Green R, Bujarski S, Lim AC, Venegas A, Ray LA. Naltrexone and alcohol effects on craving for cigarettes in heavy drinking smokers. Experimental and Clinical Psychopharmacology. PMID 30628813 DOI: 10.1037/Pha0000252  0.677
2019 Ray LA, Bujarski S, Grodin E, Hartwell E, Green R, Venegas A, Lim AC, Gillis A, Miotto K. State-of-the-art behavioral and pharmacological treatments for alcohol use disorder. The American Journal of Drug and Alcohol Abuse. 45: 124-140. PMID 30373394 DOI: 10.1080/00952990.2018.1528265  0.52
2018 Ray LA, Bujarski S, Roche DJO, Magill M. Overcoming the "Valley of Death" in Medications Development for Alcohol Use Disorder. Alcoholism, Clinical and Experimental Research. PMID 29969156 DOI: 10.1111/Acer.13829  0.454
2018 Bujarski S, Jentsch JD, Roche DJO, Ramchandani VA, Miotto K, Ray LA. Differences in the subjective and motivational properties of alcohol across alcohol use severity: application of a novel translational human laboratory paradigm. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 29802367 DOI: 10.1038/S41386-018-0086-9  0.637
2017 Ray LA, Green R, Roche DJO, Bujarski S, Hartwell EE, Lim AC, Rohrbaugh T, Ghahremani D, Hutchison K, Miotto K. Pharmacogenetic effects of naltrexone in individuals of East Asian descent: Human laboratory findings from a randomized trial. Alcoholism, Clinical and Experimental Research. PMID 29265379 DOI: 10.1111/Acer.13586  0.576
2017 Ray LA, Bujarski S, Yardley MM, Roche DJO, Hartwell EE. Differences between treatment-seeking and non-treatment-seeking participants in medication studies for alcoholism: do they matter? The American Journal of Drug and Alcohol Abuse. 1-8. PMID 28426264 DOI: 10.1080/00952990.2017.1312423  0.584
2017 Roche DJ, Worley MJ, Courtney KE, Bujarski S, London ED, Shoptaw S, Ray LA. Naltrexone moderates the relationship between cue-induced craving and subjective response to methamphetamine in individuals with methamphetamine use disorder. Psychopharmacology. PMID 28357460 DOI: 10.1007/S00213-017-4607-8  0.346
2017 Ray LA, Bujarski S, Shoptaw S, Roche DJ, Heinzerling K, Miotto K. Development of the Neuroimmune Modulator Ibudilast for the Treatment of Alcoholism: A Randomized, Placebo-Controlled, Human Laboratory Trial. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 28091532 DOI: 10.1038/Npp.2017.10  0.617
2016 Westman JG, Bujarski S, Ray LA. Impulsivity Moderates Subjective Responses to Alcohol in Alcohol-Dependent Individuals. Alcohol and Alcoholism (Oxford, Oxfordshire). PMID 28003245 DOI: 10.1093/Alcalc/Agw096  0.659
2016 Bujarski S, Ray LA. Experimental psychopathology paradigms for alcohol use disorders: Applications for translational research. Behaviour Research and Therapy. PMID 27266992 DOI: 10.1016/J.Brat.2016.05.008  0.521
2016 Green R, Bujarski S, Roche DJ, Ray LA. Relationship between negative affect and smoking topography in heavy drinking smokers. Addictive Behaviors. 61: 53-57. PMID 27240211 DOI: 10.1016/J.Addbeh.2016.05.016  0.422
2016 Ray LA, Bujarski S, Roche DJ. Subjective Response to Alcohol as a Research Domain Criterion. Alcoholism, Clinical and Experimental Research. 40: 6-17. PMID 26727518 DOI: 10.1111/Acer.12927  0.625
2016 Ray LA, Bujarski S, Roche DJO. Subjective Response to Alcohol as a Research Domain Criterion Alcoholism: Clinical and Experimental Research. 40: 6-17. DOI: 10.1111/acer.12927  0.46
2016 Hartwell EE, Bujarski S, Glasner-Edwards S, Ray LA. The association of alcohol severity and sleep quality in problem drinkers Alcohol and Alcoholism. 50: 536-541. DOI: 10.1093/alcalc/agv046  0.365
2015 Bujarski S, Lau AS, Lee SS, Ray LA. Genetic and Environmental Predictors of Alcohol Use in Asian American Young Adults. Journal of Studies On Alcohol and Drugs. 76: 690-699. PMID 26402349 DOI: 10.15288/Jsad.2015.76.690  0.602
2015 Bujarski S, Hutchison KE, Prause N, Ray LA. Functional significance of subjective response to alcohol across levels of alcohol exposure. Addiction Biology. PMID 26256114 DOI: 10.1111/Adb.12293  0.649
2015 Hartwell EE, Bujarski S, Glasner-Edwards S, Ray LA. The Association of Alcohol Severity and Sleep Quality in Problem Drinkers. Alcohol and Alcoholism (Oxford, Oxfordshire). 50: 536-41. PMID 26018218 DOI: 10.1093/Alcalc/Agv046  0.51
2015 Bujarski S, Hutchison KE, Roche DJ, Ray LA. Factor Structure of Subjective Responses to Alcohol in Light and Heavy Drinkers. Alcoholism, Clinical and Experimental Research. 39: 1193-202. PMID 26010049 DOI: 10.1111/Acer.12737  0.622
2015 Roche DJ, Bujarski S, Hartwell E, Green R, Ray LA. Combined varenicline and naltrexone treatment reduces smoking topography intensity in heavy-drinking smokers. Pharmacology, Biochemistry, and Behavior. 134: 92-8. PMID 25933795 DOI: 10.1016/J.Pbb.2015.04.013  0.345
2015 Ray LA, Bujarski S. Mechanisms of topiramate effects: refining medications development for alcoholism. Addiction Biology. PMID 25876675 DOI: 10.1111/Adb.12226  0.564
2015 Bujarski S, Roche DJ, Sheets ES, Krull JL, Guzman I, Ray LA. Modeling naturalistic craving, withdrawal, and affect during early nicotine abstinence: A pilot ecological momentary assessment study. Experimental and Clinical Psychopharmacology. 23: 81-9. PMID 25844632 DOI: 10.1037/A0038861  0.327
2015 Ray LA, Bujarski S, Courtney KE, Moallem NR, Lunny K, Roche D, Leventhal AM, Shoptaw S, Heinzerling K, London ED, Miotto K. The Effects of Naltrexone on Subjective Response to Methamphetamine in a Clinical Sample: a Double-Blind, Placebo-Controlled Laboratory Study. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 25801501 DOI: 10.1038/Npp.2015.83  0.405
2015 Bujarski S, Lau AS, Lee SS, Ray LA. Genetic and environmental predictors of alcohol use in Asian American young adults Journal of Studies On Alcohol and Drugs. 76: 690-699. DOI: 10.15288/jsad.2015.76.690  0.413
2014 Bujarski S, Ray LA. Negative affect is associated with alcohol, but not cigarette use in heavy drinking smokers. Addictive Behaviors. 39: 1723-9. PMID 25117849 DOI: 10.1016/J.Addbeh.2014.07.019  0.65
2014 Bujarski S, Roche DJ, Lunny K, Moallem NR, Courtney KE, Allen V, Hartwell E, Leventhal A, Rohrbaugh T, Ray LA. The relationship between methamphetamine and alcohol use in a community sample of methamphetamine users. Drug and Alcohol Dependence. 142: 127-32. PMID 24975477 DOI: 10.1016/J.Drugalcdep.2014.06.004  0.555
2014 Ashenhurst JR, Bujarski S, Jentsch JD, Ray LA. Modeling behavioral reactivity to losses and rewards on the Balloon Analogue Risk Task (BART): moderation by alcohol problem severity. Experimental and Clinical Psychopharmacology. 22: 298-306. PMID 24840639 DOI: 10.1037/A0036837  0.477
2014 Bujarski S, Ray LA. Subjective response to alcohol and associated craving in heavy drinkers vs. alcohol dependents: an examination of Koob's allostatic model in humans. Drug and Alcohol Dependence. 140: 161-7. PMID 24837580 DOI: 10.1016/J.Drugalcdep.2014.04.015  0.622
2014 Ray LA, Bujarski S, Squeglia LM, Ashenhurst JR, Anton RF. Interactive effects of OPRM1 and DAT1 genetic variation on subjective responses to alcohol. Alcohol and Alcoholism (Oxford, Oxfordshire). 49: 261-70. PMID 24421289 DOI: 10.1093/Alcalc/Agt183  0.608
2013 Courtney KE, Ashenhurst J, Bacio G, Moallem N, Bujarski S, Hartwell E, Ray LA. Craving and subjective responses to alcohol administration: validation of the desires for alcohol questionnaire in the human laboratory. Journal of Studies On Alcohol and Drugs. 74: 797-802. PMID 23948540 DOI: 10.15288/Jsad.2013.74.797  0.655
2013 Ray LA, Sehl M, Bujarski S, Hutchison K, Blaine S, Enoch MA. The CRHR1 gene, trauma exposure, and alcoholism risk: a test of G × E effects. Genes, Brain, and Behavior. 12: 361-9. PMID 23473364 DOI: 10.1111/Gbb.12032  0.511
2013 Ray LA, Lunny K, Bujarski S, Moallem N, Krull JL, Miotto K. The effects of varenicline on stress-induced and cue-induced craving for cigarettes. Drug and Alcohol Dependence. 131: 136-42. PMID 23298651 DOI: 10.1016/J.Drugalcdep.2012.12.015  0.309
2013 Ray LA, Bujarski S, MacKillop J, Courtney KE, Monti PM, Miotto K. Subjective response to alcohol among alcohol-dependent individuals: effects of the μ-opioid receptor (OPRM1) gene and alcoholism severity. Alcoholism, Clinical and Experimental Research. 37: E116-24. PMID 23240711 DOI: 10.1111/J.1530-0277.2012.01916.X  0.667
2013 Bujarski S, O'Malley SS, Lunny K, Ray LA. The effects of drinking goal on treatment outcome for alcoholism. Journal of Consulting and Clinical Psychology. 81: 13-22. PMID 23231573 DOI: 10.1037/A0030886  0.576
2012 Ashenhurst JR, Bujarski S, Ray LA. Delta and kappa opioid receptor polymorphisms influence the effects of naltrexone on subjective responses to alcohol. Pharmacology, Biochemistry, and Behavior. 103: 253-9. PMID 22954510 DOI: 10.1016/J.Pbb.2012.08.019  0.57
2012 Bujarski S, MacKillop J, Ray LA. Understanding naltrexone mechanism of action and pharmacogenetics in Asian Americans via behavioral economics: a preliminary study. Experimental and Clinical Psychopharmacology. 20: 181-90. PMID 22429255 DOI: 10.1037/A0027379  0.628
2012 Ray LA, Courtney KE, Bujarski S, Squeglia LM. Pharmacogenetics of alcoholism: a clinical neuroscience perspective. Pharmacogenomics. 13: 129-32. PMID 22256863 DOI: 10.2217/Pgs.11.173  0.618
2012 Ray LA, Bujarski S, Chin PF, Miotto K. Pharmacogenetics of naltrexone in asian americans: a randomized placebo-controlled laboratory study. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 37: 445-55. PMID 21900886 DOI: 10.1038/Npp.2011.192  0.564
2010 Bujarski SJ, Klanecky AK, McChargue DE. The relationship between alexithymia and alcohol-related risk perceptions: The moderating effect of general trauma in a college population. Addictive Behaviors. 35: 363-6. PMID 19926402 DOI: 10.1016/J.Addbeh.2009.10.023  0.393
Show low-probability matches.